Selected research
Market Outlook & Growth Opportunities
Global Period Cramp Pain Killer Market Outlook and Growth Opportunities 2026
Market perspective
The global Period Cramp Pain Killer market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Period Cramp Pain Killer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Period Cramp Pain Killer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Period Cramp Pain Killer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Period Cramp Pain Killer market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Period Cramp Pain Killer market include SK&F, Johnson & Johnson, Bayer, Zambon, SSP CO, Sato Pharmaceutical, Lion Corporation, Kowa Company and GSK Group, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Period Cramp Pain Killer market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Period Cramp Pain Killer and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Period Cramp Pain Killer revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Period Cramp Pain Killer market.
Period Cramp Pain Killer Segment by Company
SK&F
Johnson & Johnson
Bayer
Zambon
SSP CO
Sato Pharmaceutical
Lion Corporation
Kowa Company
GSK Group
Daewoong
Arax Co
Period Cramp Pain Killer Segment by Type
NSAID
Acetaminophen
Period Cramp Pain Killer Segment by Application
Teenagers
Adults
Period Cramp Pain Killer Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Period Cramp Pain Killer status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Period Cramp Pain Killer key companies, revenue, market share, and recent developments.
3. To split the Period Cramp Pain Killer breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Period Cramp Pain Killer market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Period Cramp Pain Killer significant trends, drivers, influence factors in global and regions.
6. To analyze Period Cramp Pain Killer competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Period Cramp Pain Killer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Period Cramp Pain Killer and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Period Cramp Pain Killer.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Period Cramp Pain Killer industry.
Chapter 3: Detailed analysis of Period Cramp Pain Killer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Period Cramp Pain Killer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Period Cramp Pain Killer in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- NSAID
- Acetaminophen
Applications
- Teenagers
- Adults
Companies covered
- SK&F
- Johnson & Johnson
- Bayer
- Zambon
- SSP CO
- Sato Pharmaceutical
- Lion Corporation
- Kowa Company
- GSK Group
- Daewoong
- Arax Co
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Period Cramp Pain Killer Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Period Cramp Pain Killer Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Period Cramp Pain Killer Market Dynamics
- 2.1 Period Cramp Pain Killer Industry Trends
- 2.2 Period Cramp Pain Killer Industry Drivers
- 2.3 Period Cramp Pain Killer Industry Opportunities and Challenges
- 2.4 Period Cramp Pain Killer Industry Restraints
3 Period Cramp Pain Killer Market by Company
- 3.1 Global Period Cramp Pain Killer Company Revenue Ranking in 2025
- 3.2 Global Period Cramp Pain Killer Revenue by Company (2021-2026)
- 3.3 Global Period Cramp Pain Killer Company Ranking (2024-2026)
- 3.4 Global Period Cramp Pain Killer Company Manufacturing Base and Headquarters
- 3.5 Global Period Cramp Pain Killer Company Product Type and Application
- 3.6 Global Period Cramp Pain Killer Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Period Cramp Pain Killer Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Period Cramp Pain Killer Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Period Cramp Pain Killer Market by Type
- 4.1 Period Cramp Pain Killer Type Introduction
- 4.1.1 NSAID
- 4.1.2 Acetaminophen
- 4.2 Global Period Cramp Pain Killer Sales Value by Type
- 4.2.1 Global Period Cramp Pain Killer Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Period Cramp Pain Killer Sales Value by Type (2021-2032)
- 4.2.3 Global Period Cramp Pain Killer Sales Value Share by Type (2021-2032)
5 Period Cramp Pain Killer Market by Application
- 5.1 Period Cramp Pain Killer Application Introduction
- 5.1.1 Teenagers
- 5.1.2 Adults
- 5.2 Global Period Cramp Pain Killer Sales Value by Application
- 5.2.1 Global Period Cramp Pain Killer Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Period Cramp Pain Killer Sales Value by Application (2021-2032)
- 5.2.3 Global Period Cramp Pain Killer Sales Value Share by Application (2021-2032)
6 Period Cramp Pain Killer Regional Value Analysis
- 6.1 Global Period Cramp Pain Killer Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Period Cramp Pain Killer Sales Value by Region (2021-2032)
- 6.2.1 Global Period Cramp Pain Killer Sales Value by Region: 2021-2026
- 6.2.2 Global Period Cramp Pain Killer Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Period Cramp Pain Killer Sales Value (2021-2032)
- 6.3.2 North America Period Cramp Pain Killer Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Period Cramp Pain Killer Sales Value (2021-2032)
- 6.4.2 Europe Period Cramp Pain Killer Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Period Cramp Pain Killer Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Period Cramp Pain Killer Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Period Cramp Pain Killer Sales Value (2021-2032)
- 6.6.2 South America Period Cramp Pain Killer Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Period Cramp Pain Killer Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Period Cramp Pain Killer Sales Value Share by Country, 2025 VS 2032
7 Period Cramp Pain Killer Country-level Value Analysis
- 7.1 Global Period Cramp Pain Killer Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Period Cramp Pain Killer Sales Value by Country (2021-2032)
- 7.2.1 Global Period Cramp Pain Killer Sales Value by Country (2021-2026)
- 7.2.2 Global Period Cramp Pain Killer Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.7.2 France Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.14.2 China Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.17.2 India Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Period Cramp Pain Killer Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Period Cramp Pain Killer Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Period Cramp Pain Killer Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 SK&F
- 8.1.1 SK&F Company Information
- 8.1.2 SK&F Business Overview
- 8.1.3 SK&F Period Cramp Pain Killer Revenue and Gross Margin (2021-2026)
- 8.1.4 SK&F Period Cramp Pain Killer Product Portfolio
- 8.1.5 SK&F Recent Developments
- 8.2 Johnson & Johnson
- 8.2.1 Johnson & Johnson Company Information
- 8.2.2 Johnson & Johnson Business Overview
- 8.2.3 Johnson & Johnson Period Cramp Pain Killer Revenue and Gross Margin (2021-2026)
- 8.2.4 Johnson & Johnson Period Cramp Pain Killer Product Portfolio
- 8.2.5 Johnson & Johnson Recent Developments
- 8.3 Bayer
- 8.3.1 Bayer Company Information
- 8.3.2 Bayer Business Overview
- 8.3.3 Bayer Period Cramp Pain Killer Revenue and Gross Margin (2021-2026)
- 8.3.4 Bayer Period Cramp Pain Killer Product Portfolio
- 8.3.5 Bayer Recent Developments
- 8.4 Zambon
- 8.4.1 Zambon Company Information
- 8.4.2 Zambon Business Overview
- 8.4.3 Zambon Period Cramp Pain Killer Revenue and Gross Margin (2021-2026)
- 8.4.4 Zambon Period Cramp Pain Killer Product Portfolio
- 8.4.5 Zambon Recent Developments
- 8.5 SSP CO
- 8.5.1 SSP CO Company Information
- 8.5.2 SSP CO Business Overview
- 8.5.3 SSP CO Period Cramp Pain Killer Revenue and Gross Margin (2021-2026)
- 8.5.4 SSP CO Period Cramp Pain Killer Product Portfolio
- 8.5.5 SSP CO Recent Developments
- 8.6 Sato Pharmaceutical
- 8.6.1 Sato Pharmaceutical Company Information
- 8.6.2 Sato Pharmaceutical Business Overview
- 8.6.3 Sato Pharmaceutical Period Cramp Pain Killer Revenue and Gross Margin (2021-2026)
- 8.6.4 Sato Pharmaceutical Period Cramp Pain Killer Product Portfolio
- 8.6.5 Sato Pharmaceutical Recent Developments
- 8.7 Lion Corporation
- 8.7.1 Lion Corporation Company Information
- 8.7.2 Lion Corporation Business Overview
- 8.7.3 Lion Corporation Period Cramp Pain Killer Revenue and Gross Margin (2021-2026)
- 8.7.4 Lion Corporation Period Cramp Pain Killer Product Portfolio
- 8.7.5 Lion Corporation Recent Developments
- 8.8 Kowa Company
- 8.8.1 Kowa Company Company Information
- 8.8.2 Kowa Company Business Overview
- 8.8.3 Kowa Company Period Cramp Pain Killer Revenue and Gross Margin (2021-2026)
- 8.8.4 Kowa Company Period Cramp Pain Killer Product Portfolio
- 8.8.5 Kowa Company Recent Developments
- 8.9 GSK Group
- 8.9.1 GSK Group Company Information
- 8.9.2 GSK Group Business Overview
- 8.9.3 GSK Group Period Cramp Pain Killer Revenue and Gross Margin (2021-2026)
- 8.9.4 GSK Group Period Cramp Pain Killer Product Portfolio
- 8.9.5 GSK Group Recent Developments
- 8.10 Daewoong
- 8.10.1 Daewoong Company Information
- 8.10.2 Daewoong Business Overview
- 8.10.3 Daewoong Period Cramp Pain Killer Revenue and Gross Margin (2021-2026)
- 8.10.4 Daewoong Period Cramp Pain Killer Product Portfolio
- 8.10.5 Daewoong Recent Developments
- 8.11 Arax Co
- 8.11.1 Arax Co Company Information
- 8.11.2 Arax Co Business Overview
- 8.11.3 Arax Co Period Cramp Pain Killer Revenue and Gross Margin (2021-2026)
- 8.11.4 Arax Co Period Cramp Pain Killer Product Portfolio
- 8.11.5 Arax Co Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst